EP1435893A1 - Sicherheitsverpackung für eine flasche für medizinische anwendungen - Google Patents

Sicherheitsverpackung für eine flasche für medizinische anwendungen

Info

Publication number
EP1435893A1
EP1435893A1 EP02796303A EP02796303A EP1435893A1 EP 1435893 A1 EP1435893 A1 EP 1435893A1 EP 02796303 A EP02796303 A EP 02796303A EP 02796303 A EP02796303 A EP 02796303A EP 1435893 A1 EP1435893 A1 EP 1435893A1
Authority
EP
European Patent Office
Prior art keywords
vial
bottle
packaging
medical use
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP02796303A
Other languages
English (en)
French (fr)
Other versions
EP1435893B1 (de
Inventor
Farid Hamedi-Sangsari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAPTECH
Original Assignee
MAP France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAP France SAS filed Critical MAP France SAS
Publication of EP1435893A1 publication Critical patent/EP1435893A1/de
Application granted granted Critical
Publication of EP1435893B1 publication Critical patent/EP1435893B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1475—Inlet or outlet ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/2013—Piercing means having two piercing ends
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2065—Connecting means having aligning and guiding means

Definitions

  • the subject of the present invention is a safety packaging for a vial for medical use, in particular for a vial containing substances potentially dangerous for users or the environment (anticancer, antibiotics, etc.).
  • These medicinal substances are generally packaged in glass bottles sealed with a perforable elastomer stopper, itself fixed in an inviolable manner on the bottle by crimping an aluminum cap.
  • These drugs can be in the form of a liquid, a powder or a lyophilisate. They are intended to be transferred to an infusion bag containing an infusion liquid (NaCl, glucose, etc.) and then to be injected into the patient.
  • the drugs stored in the vial in the form of a liquid can be directly transferred to the infusion bag, those in the form of a powder or a lyophilisate must first be reconstituted by dissolving in a solvent.
  • the object of the present invention is therefore to provide a device offering the best guarantees of security with regard to both the risk of breakage of the bottle, the risk of accidental puncture and the risk of leakage.
  • the patent FR1380706 describes a device for transferring a container into another consisting of a plate crossed by two hollow pointed needles at their two ends.
  • Patent FR1545963 describes a transfer device constituted by a hollow cylinder provided with a stop diaphragm crossed by a perforated needle comprising two points.
  • Patent FR2302134 describes a device for transferring the liquid content of a container through the stopper or the lid thereof into a second container comprising a tubular body covering the necks of the two containers, a hollow needle having two pointed ends d 'a sufficient length to pass through the plugs or lids of the containers and another hollow needle, one end of which passes through the plug or lids of one of the containers and the other end remains in communication with the atmosphere.
  • EP0192661 and EP0195018 describe devices for the reconstitution of medicaments making it possible to connect a vial of powder and an infusion bag using a twin-pointed needle and having means for preventing accidental separation of the elements.
  • Patent FR2780878 describes a transfer cap for the passage of a medicament between a vial and a solution bag comprising a one-piece tubular body and a needle, characterized by particular snap-on means.
  • connection devices between a closed container and a container in the form in particular of ready-to-use assemblies.
  • These different devices are either pre-mounted by clipping on the neck of the bottle, or are delivered separately, preferably in a sterile blister, and clipped on the bottle by the nursing staff.
  • the ready-to-use systems are simpler to handle and they avoid the risk of contamination when clipping onto the bottle; however, they are expensive and do not solve the problem of breaking glass bottles.
  • the present invention makes it possible to obtain a cheap transfer device, easy to manufacture and meeting both the objectives of personnel safety and protection against breakage.
  • the device which is the subject of the present invention is a cylindrical monobloc body made of plastic material consisting of two parts: a lower part intended to completely cover the glass bottle and possibly comprising at its base means for stabilizing the device in a vertical position and an upper part of smaller diameter constituted by a cylindrical chamber containing means, for example a twin-pointed needle, allowing the transfer of the contents of the bottle into a container, such as an infusion bag.
  • a container such as an infusion bag.
  • Figure 1 is a sectional view of a standard vial containing a powdered drug.
  • Figure 2 is a view of a standard infusion bag filled with solution for injection.
  • Figure 3 is an axial sectional view of the packaging device according to the present invention with a bottle in the "storage” position.
  • Figure 4 is an axial sectional view of the packaging device according to the present invention with a bottle in the "use” position.
  • Figure 5 is a partial sectional view of a particular embodiment of the stop means preventing inadvertent drilling of the plug.
  • Figure 6 is a view of a particular embodiment of the base of the device.
  • FIG. 1 represents a standard glass bottle (1) closed by an elastomer stopper (2) fixed to the bottle by an aluminum cap (3).
  • the vial contains a medicine in the form of a powder or a lyophilisate (4). But it can be a sterile liquid.
  • FIG. 2 represents a standard infusion bag (6) provided with an injection site (5), intended for the transfer of the drug.
  • FIG. 3 represents a device constituted by a tubular monobloc body comprising a partition (12), perpendicular to the axis of the tubular body, which delimits two open chambers (A) and (B).
  • the partition (12) which constitutes the base of the chamber (A) is provided with means for holding in place a twin-pointed needle (10, 11).
  • the height of the cylindrical chamber (A) is chosen so as to completely protect the point (10) of the needle.
  • the internal diameter of the chamber (A) is less than that of the chamber (B) but sufficient to accept the passage of the injection sites (5) equipping the infusion bags.
  • the twin-point needle (10, 11) can be held in the partition (12) by any suitable means, such as gluing, welding, overmolding.
  • the chamber (B) into which the other end (11) of the twin-point needle opens out consists of a tube (13).
  • This chamber (B) is intended to cover the bottle (1).
  • the diameter of the tube (13) is therefore chosen so as to be able to insert the bottle (1) into the tube.
  • the diameter of the tube (13) is slightly greater than the diameter of the body of the bottle (1).
  • the tube (13) is narrowed at its upper end to form a tube (13a) with a diameter less than that of the tube (13), the diameter of the tube (13a) being slightly greater than the diameter of the cover (3 ) from the bottle.
  • the diameters are chosen so as to allow the insertion of bottles of slightly different dimensions.
  • the height of the tube (13a) is chosen as a function of the height h stopper (2) - cover (3) of the bottle (1).
  • This embodiment comprising a tube (13) and a tube (13a) allows to conform to the shape of the bottle (1) by improving the connection between the bottle (1) and the tip.
  • the wall of the tube (13) covering the bottle can be full or have recesses over part or all of the height.
  • the bottle is kept in the storage position using retaining means (8) intended to prevent the bottle from leaving the chamber (B) and retaining means (7) intended to prevent piercing. untimely cap.
  • the retaining means (8) are sufficiently elastic to allow the force to be introduced into the device.
  • these retaining means consist of axial ribs formed inside the tube (13) which provide a friction force on the body of the bottle.
  • the retaining means (8) can be replaced by a thumb-perforable cover (film or welded paper) or by a captive plug.
  • the retaining means (7) can be formed by any means capable of ensuring an elastic stop function, for example a continuous annular bead or not.
  • the tube (13) comprises at its base means intended to increase the stability of the device in the vertical position.
  • This is for example a flange (9), possibly comprising additional means, for example flats, to prevent the device from rolling when it is in a horizontal position.
  • the tubular monobloc body is made of an impact-resistant plastic material, to avoid the risks of breakage, and preferably transparent to allow the reading of the information mentioned on the body of the bottle and the monitoring of its content. Any plastic material having such properties can be used, such as polypropylene, polycarbonate or K resin.
  • the content of the bottle (1) is placed in communication with the content of the infusion bag (6) after puncturing of the stopper (2) by the tip (11) and of the injection site (5) by the tip (10).
  • the bottle (1) slides in the chamber (B) under the action of a thrust exerted on the bottom (14) of the bottle.
  • the bottle moves until it comes up against the partition (12), which allows the tip (11) to pierce the stopper (2).
  • a push is exerted on the bottom (14) of the bottle with the thumb.
  • the retaining means (7) keep the bottle in the use position and prevent the axial movement of the bottle down.
  • the injection site (5) of the infusion bag (6) is pierced in a conventional manner by forcefully introducing the site into the chamber (A).
  • FIG. 5 represents a particular embodiment of the stop means (7) preventing untimely drilling of the plug.
  • the elastic retaining means consist of tongues (15, 16) whose free ends are oriented towards the inside of the tube (13a).
  • the elastic means (8) can also consist of tongues such as the tongues (15, 16).
  • FIG. 6 represents a particular embodiment of the base of the device.
  • the base of the tube (13) has one or more openings (17) intended to facilitate the pushing on the bottom of the bottle. We prefer systems with a single opening to avoid the risk of pulling out of the bottle.
  • the figures illustrate an embodiment in which a bottle (1) and an infusion bag (6) are placed in communication.
  • the system can be used to port a vial to another type of container.
  • the exemplified embodiments relate to a device with a twin-pointed needle, but it is also possible to use a device with a needle on the bottle side and a Luer site on the pocket side.
  • the device according to the invention is a one-piece plastic body. It is therefore easy to produce by implementing the conventional processes of the plastics industry.
  • the device is sterilized with ethylene oxide, by steam or by radiation.
  • the device is placed in advance on the bottle (1).
  • the device / bottle assembly is preassembled, placed in a blister and sterilized as above.
  • the device can be provided with a removable plug sealing off chamber A, then after mounting the bottle in chamber B the bottom of chamber B can be sealed with a "heat-sealable" paper, allowing sterilization of the whole with ethylene oxide or steam.
  • a "heat-sealable" paper allowing sterilization of the whole with ethylene oxide or steam.
  • This variant avoids blistering the device-bottle assembly. During use, the nurse removes the cap, then pushes the bottle through the paper, which will tear effortlessly.
  • the device is placed on the bottle (1) at the time of its use. Just remove the cap (3) and forcefully insert the bottle into the tube (13).

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Buffer Packaging (AREA)
  • Closures For Containers (AREA)
EP20020796303 2001-08-22 2002-08-22 Sicherheitsverpackung für eine flasche für medizinische anwendungen Expired - Lifetime EP1435893B1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0110982 2001-08-22
FR0110982A FR2828802A1 (fr) 2001-08-22 2001-08-22 Conditionnement de securite pour flacon a usage medical
FR0116379A FR2828803B1 (fr) 2001-08-22 2001-12-18 Conditionnement de securite pour flacon a usage medical
FR0116379 2001-12-18
PCT/FR2002/002920 WO2003017916A1 (fr) 2001-08-22 2002-08-22 Conditionnement de securite pour flacon a usage medical

Publications (2)

Publication Number Publication Date
EP1435893A1 true EP1435893A1 (de) 2004-07-14
EP1435893B1 EP1435893B1 (de) 2008-02-06

Family

ID=26213151

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20020796303 Expired - Lifetime EP1435893B1 (de) 2001-08-22 2002-08-22 Sicherheitsverpackung für eine flasche für medizinische anwendungen

Country Status (8)

Country Link
EP (1) EP1435893B1 (de)
AT (1) ATE385418T1 (de)
DE (1) DE60224940T2 (de)
DK (1) DK1435893T3 (de)
ES (1) ES2300504T3 (de)
FR (2) FR2828802A1 (de)
PT (1) PT1435893E (de)
WO (1) WO2003017916A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020167910A1 (en) * 2019-02-12 2020-08-20 Amgen Inc. Systems and approaches for drug delivery device reconstitution
CN116850052A (zh) * 2023-07-21 2023-10-10 苏州恒瑞宏远医疗科技有限公司 给药装置

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863161B1 (fr) 2003-12-05 2006-09-01 Map France Capuchon pour conditionnement de securite pour flacon a usage medical
US7615041B2 (en) 2004-07-29 2009-11-10 Boston Scientific Scimed, Inc. Vial adaptor
FR2878737B1 (fr) * 2004-12-07 2007-03-16 Maptech Soc Par Actions Simpli Dispositif de securite pour flacon a usage medical
JP5981341B2 (ja) * 2009-09-14 2016-08-31 ネステク ソシエテ アノニム ホイルシールと貫通手段を伴う包装体
US20160039546A1 (en) * 2014-08-07 2016-02-11 Greg Gardner Condiment transfer device and method
ITUB20153260A1 (it) * 2015-08-27 2017-02-27 Paolo Gobbi Frattini S R L Tappo di chiusura ermetica per flacone sterile sigillato di contenimento di sostanze attive medicinali o nutrizionali, idoneo per la connessione sterile con un contenitore di soluzione liquida diluente, e sistema di connessione sterile utilizzante detto tappo di chiusura.
CH716516A1 (fr) * 2019-08-22 2021-02-26 Mpi Int Sa Procédé de préparation d'au moins une solution injectable en poche, unité pour la préparation de ladite solution injectable et poche contenant ladite solution injectable.
CH716733A1 (fr) * 2019-10-29 2021-04-30 Mpi Int Sa Procédé de préparation d'au moins une solution injectable en ampoule, unité pour la préparation de ladite solution injectable et ampoule contenant ladite solution injectable.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1380706A (fr) 1963-10-23 1964-12-04 Dispositif pour le transvasement d'un fluide d'un récipient à un autre
FR1545963A (fr) 1967-11-07 1968-11-15 Abc Ist Biolog Chem Spa Emballage de deux substances séparées et miscibles, dont une au moins liquide, avec dispositif de transvasement
FR2302134A1 (fr) 1975-02-28 1976-09-24 Merieux Inst Dispo
US4607671A (en) 1984-08-21 1986-08-26 Baxter Travenol Laboratories, Inc. Reconstitution device
US4759756A (en) 1984-09-14 1988-07-26 Baxter Travenol Laboratories, Inc. Reconstitution device
IE62230B1 (en) * 1987-04-02 1995-01-11 Drg Uk Ltd Apparatus for contacting material such as a drug with a fluid
DE19513666C1 (de) * 1995-04-11 1996-11-28 Behringwerke Ag Vorrichtung zum Zusammenführen einer ersten flüssigen und einer zweiten festen oder flüssigen Komponente mittels Unterdruck unter sterilen Bedingungen
FR2738550B1 (fr) 1995-09-11 1997-11-07 Biodome Dispositif d'obturation d'un recipient lui-meme ferme, ensemble pour dispenser un produit comprenant un tel recipient et un tel dispositif d'obturation
WO1997020536A1 (fr) * 1995-12-06 1997-06-12 Gabriel Meyer Dispositif pour la preparation d'une solution medicamenteuse reconstituee a partir de deux composants
FR2753624B1 (fr) 1996-09-25 1999-04-16 Biodome Dispositif de connexion, en particulier entre un recipient avec bouchon perforable et une seringue
FR2780878B1 (fr) 1998-07-10 2000-09-29 Frederic Senaux Capuchon de transfert encliquetable
FR2790749B1 (fr) * 1999-03-10 2001-05-18 Maco Pharma Sa Dispositif de transfert d'une substance contenue dans un flacon dans une poche de solute

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03017916A1 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020167910A1 (en) * 2019-02-12 2020-08-20 Amgen Inc. Systems and approaches for drug delivery device reconstitution
CN116850052A (zh) * 2023-07-21 2023-10-10 苏州恒瑞宏远医疗科技有限公司 给药装置

Also Published As

Publication number Publication date
PT1435893E (pt) 2008-05-09
FR2828803A1 (fr) 2003-02-28
FR2828802A1 (fr) 2003-02-28
DE60224940T2 (de) 2008-08-21
WO2003017916A1 (fr) 2003-03-06
EP1435893B1 (de) 2008-02-06
DE60224940D1 (de) 2008-03-20
ATE385418T1 (de) 2008-02-15
ES2300504T3 (es) 2008-06-16
FR2828803B1 (fr) 2004-10-22
DK1435893T3 (da) 2008-06-09

Similar Documents

Publication Publication Date Title
EP1827353B1 (de) Sicherheitsvorrichtung zur medizinischen anwendung
EP0403626B1 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz
EP0406374B1 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz
EP1079789B1 (de) Ampulle zur aufnahme einer medizinischen flüssigkeit
EP1226077B1 (de) Einsatzbereite verbindungsvorrichtung
EP1694269B1 (de) Kappe für die sichere verpackng einer medizinflasche
EP0717611B1 (de) Spritzenvorrichtung zum mischen von zwei präparaten
EP0850178B1 (de) Vorrichtung mit originalitätssicherung zum anschluss an einen geschlossenen behälter
EP1349530A1 (de) Ampulle zur aufnahme und zum transferieren einer medizinischen flüssigkeit oder eines pulvers
US7799009B2 (en) Tabletop drug dispensing vial access adapter
US20050124964A1 (en) Table top drug dispensing vial access adapter
EP1034772B1 (de) Vorrichtung zum Übertragen einer in einem Flacon enthaltenen Substanz in einen Beutel der eine Lösung enthält
FR2717086A1 (fr) Dispositif de seringue pour le mélange de deux composés.
WO1997020536A1 (fr) Dispositif pour la preparation d'une solution medicamenteuse reconstituee a partir de deux composants
EP1435893B1 (de) Sicherheitsverpackung für eine flasche für medizinische anwendungen
EP1005429A1 (de) Mischflasche zur abgabe einer mischung aus zwei vor der abgabe voneinander getrennten produkten und zur deren injekton mittels einer spritze
FR2618682A1 (fr) Dispositif pour la fermeture et le raccordement de recipients pour liquides de perfusion
FR2708205A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2708469A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2715311A1 (fr) Dispositif de seringue pour le mélange de deux composés.
FR2714294A1 (fr) Dispositif de seringue pour le mélange de deux composés.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040319

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MAPTECH

17Q First examination report despatched

Effective date: 20060728

17Q First examination report despatched

Effective date: 20060728

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REF Corresponds to:

Ref document number: 60224940

Country of ref document: DE

Date of ref document: 20080320

Kind code of ref document: P

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20080428

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2300504

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20080401154

Country of ref document: GR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080206

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080206

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080206

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20081107

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080506

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080206

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080206

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080822

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080206

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20110901

Year of fee payment: 10

Ref country code: DK

Payment date: 20110830

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20120829

Year of fee payment: 11

Ref country code: GB

Payment date: 20120903

Year of fee payment: 11

Ref country code: SE

Payment date: 20120829

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20120831

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20120831

Year of fee payment: 11

Ref country code: DE

Payment date: 20120831

Year of fee payment: 11

Ref country code: IT

Payment date: 20120827

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20120222

Year of fee payment: 11

Ref country code: NL

Payment date: 20120831

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20120831

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20120831

Year of fee payment: 11

BERE Be: lapsed

Owner name: MAPTECH

Effective date: 20130831

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20140224

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20140301

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

Ref country code: DK

Ref legal event code: EBP

Effective date: 20130831

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 385418

Country of ref document: AT

Kind code of ref document: T

Effective date: 20130822

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20130822

REG Reference to a national code

Ref country code: GR

Ref legal event code: ML

Ref document number: 20080401154

Country of ref document: GR

Effective date: 20140305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140301

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140301

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130823

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130831

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130831

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60224940

Country of ref document: DE

Effective date: 20140301

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130831

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130822

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130822

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140305

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140224

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130822

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130822

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130831

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20150710

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130823

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20170828

Year of fee payment: 16

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831